LncRNA PVT1 is a novel mediator promoting the angiogenesis response associated with collateral artery formation

You Li1,2, Jing-Yi Xue3,4, Shuang Chen1,2, Chao Wang1,2, Ping Sun1,2, Shuai Fu1,2, Yitong Li1, Peng Zhao1,2, Jiawei Tian1, Guo-Qing Du1,5
1Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
2The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, Heilongjiang, China
3Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, China
4Department of Cardiology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
5Department of Ultrasound, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

Tài liệu tham khảo

Akboga, 2014, Relationship between plasma apelin level and coronary collateral circulation, Atherosclerosis, 235, 289, 10.1016/j.atherosclerosis.2014.04.029 Batista, 2013, Long noncoding RNAs: cellular address codes in development and disease, Cell, 152, 1298, 10.1016/j.cell.2013.02.012 Derrien, 2012, The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression, Genome Res, 22, 1775, 10.1101/gr.132159.111 Fei, 2018, The relationship of plasma miR-503 and coronary collateral circulation in patients with coronary artery disease, Life Sci., 207, 145, 10.1016/j.lfs.2018.06.001 Fei, 2018, The relationship of plasma miR-503 and coronary collateral circulation in patients with coronary artery disease, Life Sci., 207, 145, 10.1016/j.lfs.2018.06.001 Huang, 2020, Overexpression of long non-coding RNA ANRIL promotes post-ischaemic angiogenesis and improves cardiac functions by targeting Akt, J. Cell Mol. Med., 24, 6860, 10.1111/jcmm.15343 Huarte, 2010, A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response, Cell, 142, 409, 10.1016/j.cell.2010.06.040 Khand, 2013, The collateral circulation of the heart in coronary total arterial occlusions in man: systematic review of assessment and pathophysiology, Am. Heart J., 166, 941, 10.1016/j.ahj.2013.09.010 Khoo, 2014, Determination of the severity of underlying lesions in acute myocardial infarction on the basis of collateral vessel development, Coron. Artery Dis., 25, 493, 10.1097/MCA.0000000000000115 Kopp, 2018, Functional classification and experimental dissection of long noncoding RNAs, Cell, 172, 393, 10.1016/j.cell.2018.01.011 Levin, 2019, Treating disease at the RNA level with oligonucleotides, N. Engl. J. Med., 380, 57, 10.1056/NEJMra1705346 Li, 2017, lncRNAs HIF1A-AS2 facilitates the up-regulation of HIF-1alpha by sponging to miR-153-3p, whereby promoting angiogenesis in HUVECs in hypoxia, Biomed. Pharm., 96, 165, 10.1016/j.biopha.2017.09.113 Li, 2017, MiRNA-29b suppresses tumor growth through simultaneously inhibiting angiogenesis and tumorigenesis by targeting Akt3, Cancer Lett., 397, 111, 10.1016/j.canlet.2017.03.032 Liu, 2019, Linc00299/miR-490-3p/AURKA axis regulates cell growth and migration in atherosclerosis, Heart Vessels, 34, 1370, 10.1007/s00380-019-01356-7 Lu, 2020, LncRNA-LUNAR1 levels are closely related to coronary collaterals in patients with chronic total coronary occlusion, J. Cardiovasc Transl. Res., 13, 171, 10.1007/s12265-019-09917-x Mao, 2019, PVT1 promotes angiogenesis by regulating miR-29c/vascular endothelial growth factor (VEGF) signaling pathway in non-small-cell lung cancer (NSCLC), Med. Sci. Monit., 25, 5418, 10.12659/MSM.917601 Michalik, 2014, Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth, Circ. Res., 114, 1389, 10.1161/CIRCRESAHA.114.303265 Pries, 2015, Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation, Eur. Heart J., 36, 3134, 10.1093/eurheartj/ehv100 Ruan, 2018, Knockdown of long noncoding RNA MEG3 impairs VEGF-stimulated endothelial sprouting angiogenesis via modulating VEGFR2 expression in human umbilical vein endothelial cells, Gene, 649, 32, 10.1016/j.gene.2018.01.072 Sahin, 2014, Impact of coronary collateral circulation and severity of coronary artery disease in the development of postoperative atrial fibrillation, Inter. Cardiovasc Thorac. Surg., 19, 394, 10.1093/icvts/ivu158 Seiler, 2013, The human coronary collateral circulation: development and clinical importance, Eur. Heart J., 34, 2674, 10.1093/eurheartj/eht195 Shigeyasu, 2020, The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer, Mol. Cancer, 19, 155, 10.1186/s12943-020-01277-4 Shiojima, 2002, Role of Akt signaling in vascular homeostasis and angiogenesis, Circ. Res, 90, 1243, 10.1161/01.RES.0000022200.71892.9F Tay, 2014, The multilayered complexity of ceRNA crosstalk and competition, Nature, 505, 344, 10.1038/nature12986 Wu, 2020, lncRNA PVT1 promotes tumorigenesis of colorectal cancer by stabilizing miR-16-5p and interacting with the VEGFA/VEGFR1/AKT axis, Mol. Ther. Nucleic Acids, 20, 438, 10.1016/j.omtn.2020.03.006 Zeng, 2019, LncRNA ANRIL promotes angiogenesis and thrombosis by modulating microRNA-99a and microRNA-449a in the autophagy pathway, Am. J. Transl. Res, 11, 7441 Zhao, 2018, LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer, Oncogene, 37, 4094, 10.1038/s41388-018-0250-z Zheng, 2018, lncRNA PVT1 promotes the angiogenesis of vascular endothelial cell by targeting miR26b to activate CTGF/ANGPT2, Int J. Mol. Med, 42, 489 Zhu, 2021, Downregulation of microRNA-15b-5p Targeting the Akt3-Mediated GSK-3beta/beta-catenin signaling pathway inhibits cell apoptosis in parkinson's disease, Biomed. Res Int, 2021, 10.1155/2021/8814862 Zhu, 2017, MiR-15b-5p regulates collateral artery formation by targeting AKT3 (Protein Kinase B-3), Arterioscler. Thromb. Vasc. Biol., 37, 957, 10.1161/ATVBAHA.116.308905 Zimarino, 2014, The dynamics of the coronary collateral circulation, Nat. Rev. Cardiol., 11, 191, 10.1038/nrcardio.2013.207